跳至主要内容
临床试验/NCT02143310
NCT02143310已完成不适用

A Multi-Centre Study to Evaluate the Safety of Use of Electronic Vapour Products for Two Years

Fontem Ventures BV4 个研究点 分布在 1 个国家目标入组 209 人开始时间: 2014年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
209
试验地点
4
主要终点
Blood Pressure

研究概览

简要总结

Electronic Vapour Products (EVPs) is a relatively new class of consumer products that are otherwise known as electronic cigarettes devices/systems. These may look like conventional cigarettes but do not contain tobacco.

The 'vapour' produced by such devices typically consists of humectants (propylene glycol or glycerol), nicotine, water, and flavours.

This trial is to evaluate the safety and tolerability of an EVP over two years.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject who participated in the EVP G1 S2 study (S2)
  • Willingness to use the EVP provided by the sponsor for two years as the only nicotine containing product
  • No clinically significant abnormalities during the S2 study

排除标准

  • Subjects who have used nicotine replacement therapy during the S2 study
  • Subjects with relevant illness history
  • Subjects with history of drug or alcohol abuse
  • Subjects with lung function test or vital signs considered unsuitable Subjects who are trying to stop smoking
  • Female subjects who are pregnant, or unwilling to use acceptable contraceptive method for the duration of the study.

研究组 & 干预措施

EVP

Experimental

Subject who use the EVP for up to 2 years

干预措施: EVP (Device)

结局指标

主要结局

Blood Pressure

时间窗: 24 months

Sitting systolic blood pressure (mmHg)

Electrocardiogram (ECG): PR Interval

时间窗: 24 months

In electrocardiography, the PR interval is the period that extends from the beginning of the P wave (the onset of atrial depolarization) until the beginning of the QRS complex. Variations in the PR interval can be associated with certain medical conditions.

Lung Function Tests

时间窗: 24 months

Forced Vital Capacity (FVC)

Clinical Laboratory Parameters

时间窗: 24 months

High density lipoprotein (HDL) cholesterol, change from baseline (BL)

次要结局

  • Biomarkers of Exposure to Nicotine(24 months)
  • Nicotine Withdrawal Symptoms(24 Months)
  • Biomarkers of Effect(24 months)

研究者

发起方
Fontem Ventures BV
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验